BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30016638)

  • 1. An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition.
    Hoshiba T
    Exp Cell Res; 2018 Sep; 370(2):571-578. PubMed ID: 30016638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.
    Hoshiba T; Tanaka M
    Biochim Biophys Acta; 2016 Nov; 1863(11):2749-2757. PubMed ID: 27558478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
    Rajesh Y; Biswas A; Mandal M
    Exp Cell Res; 2017 Oct; 359(2):299-311. PubMed ID: 28844885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
    Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
    Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages.
    Hoshiba T; Tanaka M
    Biochem Biophys Res Commun; 2013 Sep; 439(2):291-6. PubMed ID: 23978418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
    Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of TMEM45A overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal cancer cells through inhibition of TGF-β signalling pathway.
    Zhu M; Jiang B; Yan D; Wang X; Ge H; Sun Y
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):503-516. PubMed ID: 31788833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
    [No Abstract]   [Full Text] [Related]  

  • 14. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
    Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
    Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.
    Ruff M; Leyme A; Le Cann F; Bonnier D; Le Seyec J; Chesnel F; Fattet L; Rimokh R; Baffet G; Théret N
    PLoS One; 2015; 10(9):e0139179. PubMed ID: 26407179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture.
    Mukaratirwa S; Koninkx JF; Gruys E; Nederbragt H
    Int J Exp Pathol; 2005 Aug; 86(4):219-29. PubMed ID: 16045544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative.
    Lee TY; Liu CL; Chang YC; Nieh S; Lin YS; Jao SW; Chen SF; Liu TY
    Oncotarget; 2016 Apr; 7(17):23512-20. PubMed ID: 26992205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
    Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
    FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.